The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review

citation_journal_title=N Engl J Med; citation_title=Inflammatory muscle diseases; citation_author=MC Dalakas; citation_volume=372; citation_publication_date=2015; citation_pages=1734-1747; citation_doi=10.1056/NEJMra1402225; citation_id=CR1 citation_journal_title=Ann Rheum Dis; citation_title=2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups; citation_author=IE Lundberg, A Tjärnlund, M Bottai, VP Werth, C Pilkington, M Visser; citation_volume=76; citation_publication_date=2017; citation_pages=1955-1964; citation_doi=10.1136/annrheumdis-2017-211468; citation_id=CR2 citation_journal_title=Nat Rev Dis Primers; citation_title=Idiopathic inflammatory myopathies; citation_author=IE Lundberg, M Fujimoto, J Vencovsky, R Aggarwal, M Holmqvist, L Christopher-Stine; citation_volume=7; citation_publication_date=2021; citation_pages=86; citation_doi=10.1038/s41572-021-00321-x; citation_id=CR3 citation_journal_title=Nat Rev Rheumatol; citation_title=Risk factors and disease mechanisms in myositis; citation_author=FW Miller, JA Lamb, J Schmidt, K Nagaraju; citation_volume=14; citation_publication_date=2018; citation_pages=255-268; citation_doi=10.1038/nrrheum.2018.48.5; citation_id=CR4 citation_journal_title=Arthritis Rheum; citation_title=Brief report: Association of HLA-DRB1*0101/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population; citation_author=T Gono, Y Kawaguchi, M Kuwana, T Sugiura, T Furuya, K Takagi; citation_volume=64; citation_publication_date=2012; citation_pages=3736-3740; citation_doi=10.1002/art.34657; citation_id=CR5 citation_journal_title=J Rheumatol; citation_title=HLA-DRB1 alleles as genetic risk factors for the development of anti-MDA5 antibodies in patients with dermatomyositis; citation_author=Z Chen, Y Wang, M Kuwana, X Xu, W Hu, X Feng; citation_volume=44; citation_publication_date=2017; citation_pages=1389-1393; citation_doi=10.3899/jrheum.170165; citation_id=CR6 citation_journal_title=Rheumatology; citation_title=Clinical phenotype, autoantibody profile and HLA-DR-type in Vietnamese patients with idiopathic inflammatory myopathies; citation_author=T Nguyen Thi Phuong, L Nguyen Thi Ngoc, H Nguyen Xuan, J Rönnelid, L Padyukov, IE Lundberg; citation_volume=58; citation_publication_date=2019; citation_pages=361-3; citation_doi=10.1093/rheumatology/key313; citation_id=CR7 citation_journal_title=Medicine; citation_title=Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies; citation_author=TP O’Hanlon, DM Carrick, IN Targoff, FC Arnett, JD Reveille, M Carrington; citation_volume=85; citation_publication_date=2006; citation_pages=111-127; citation_doi=10.1097/01.md.0000217525.82287.eb; citation_id=CR8 citation_journal_title=Arthritis Rheum; citation_title=HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies; citation_author=TP O’Hanlon, LG Rider, G Mamyrova, IN Targoff, FC Arnett, JD Reveille; citation_volume=54; citation_publication_date=2006; citation_pages=3670-3681; citation_doi=10.1002/art.22205; citation_id=CR9 citation_journal_title=J Rheumatol; citation_title=Association of HLA class I and class II alleles with myositis in Japanese patients; citation_author=T Furuya, M Hakoda, K Higami, H Ueda, N Tsuchiya, K Tokunaga; citation_volume=25; citation_publication_date=1998; citation_pages=1109-1114; citation_id=CR10 citation_journal_title=Rheum Dis Clin North Am; citation_title=Environmental risks for Inflammatory myopathies; citation_author=WI Che, IE Lundberg, M Holmqvist; citation_volume=48; citation_publication_date=2022; citation_pages=861-874; citation_doi=10.1016/j.rdc.2022.06.007; citation_id=CR11 citation_journal_title=Curr Rheumatol Rep; citation_title=COVID-19 and myositis: what we know so far; citation_author=A Saud, R Naveen, R Aggarwal, L Gupta; citation_volume=23; citation_publication_date=2021; citation_pages=63; citation_doi=10.1007/s11926-021-01023-9; citation_id=CR12 citation_journal_title=J Clin Rheumatol; citation_title=Immune checkpoint inhibitor–associated myositis; citation_author=D Saygin, N Ghosh, P Reid; citation_volume=28; citation_publication_date=2022; citation_pages=367-373; citation_doi=10.1097/RHU.0000000000001874; citation_id=CR13 citation_journal_title=Rheumatol Int; citation_title=A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19; citation_author=K Kouranloo, M Dey, H Elwell, A Nune; citation_volume=43; citation_publication_date=2023; citation_pages=1-23; citation_doi=10.1007/s00296-023-05283-9; citation_id=CR14 citation_journal_title=Cells; citation_title=New onset of autoimmune diseases following COVID-19 diagnosis; citation_author=AE Gracia-Ramos, E Martin-Nares, G Hernández-Molina; citation_volume=10; citation_publication_date=2021; citation_pages=3592; citation_doi=10.3390/cells10123592.16; citation_id=CR15 citation_journal_title=Front Immunol; citation_title=Autoimmune and rheumatic manifestations associated with COVID-19 in adults: an updated systematic review; citation_author=K-T Tang, B-C Hsu, D-Y Chen; citation_volume=12; citation_publication_date=2021; citation_pages=645013; citation_doi=10.3389/fimmu.2021.645013; citation_id=CR16 citation_journal_title=Rheumatology; citation_title=Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey; citation_author=LG Rider, CG Parks, J Wilkerson, AI Schiffenbauer, RK Kwok, P NorooziFarhadi; citation_volume=61; citation_publication_date=2022; citation_pages=SI143-50; citation_doi=10.1093/rheumatology/keac249.18; citation_id=CR17 citation_journal_title=Front Immunol; citation_title=The flare of rheumatic disease after SARS-CoV-2 vaccination: a review; citation_author=Y Xie, Y Liu, Y Liu; citation_volume=13; citation_publication_date=2022; citation_pages=919979; citation_doi=10.3389/fimmu.2022.919979; citation_id=CR18 citation_journal_title=Immunol; citation_title=New-onset autoimmune phenomena post-COVID-19 vaccination; citation_author=Y Chen, Z Xu, P Wang, X-M Li, Z-W Shuai, D-Q Ye; citation_volume=165; citation_publication_date=2022; citation_pages=386-401; citation_doi=10.1111/imm.13443; citation_id=CR19 citation_journal_title=Autoimmun Rev; citation_title=Insights into new-onset autoimmune diseases after COVID-19 vaccination; citation_author=M Guo, X Liu, X Chen, Q Li; citation_volume=22; citation_publication_date=2023; citation_pages=103340; citation_doi=10.1016/j.autrev.2023.103340; citation_id=CR20 citation_journal_title=Clin Exp Rheumatol; citation_title=Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience; citation_author=F Kharouf, A Kenig, E Bohbot, L Rubin, H Peleg, O Shamriz; citation_volume=41; citation_publication_date=2023; citation_pages=316-21; citation_doi=10.55563/clinexprheumatol/970881; citation_id=CR21 citation_journal_title=Rheumatol Int; citation_title=New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review; citation_author=M-T Holzer, M Krusche, N Ruffer, H Haberstock, M Stephan, TB Huber; citation_volume=42; citation_publication_date=2022; citation_pages=2267-2276; citation_doi=10.1007/s00296-022-05176-3.23; citation_id=CR22 Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun. 2021;12:5417.  https://doi.org/10.1038/s41467-021-25509-3 . This longitudinal analysis of prototypical autoantibodies associated with SAIRDs in hospitalized COVID-19 patients found that a subset of autoantibodies developed de novo following SARS-CoV-2 infection. citation_journal_title=Clin Transl Sci; citation_title=Screening and characterization of myositis-related autoantibodies in COVID-19 patients; citation_author=K-F Teo, D-Y Chen, J-T Hsu, Y-H Lai, C-K Chang, P-R Hsueh; citation_volume=16; citation_publication_date=2023; citation_pages=140-150; citation_doi=10.1111/cts.13434; citation_id=CR24 citation_journal_title=Cureus; citation_title=Prevalence of myositis-specific autoantibodies and myositis-associated autoantibodies in COVID-19 patients: a pilot study and literature review; citation_author=I Swartzman, JJ Gu, Z Toner, R Grover, L Suresh, LE Ullman; citation_volume=14; citation_publication_date=2022; citation_pages=e29752; citation_doi=10.7759/cureus.29752; citation_id=CR25 citation_journal_title=J Virol; citation_title=SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells; citation_author=A Rebendenne, ALC Valadão, M Tauziet, G Maarifi, B Bonaventure, J McKellar; citation_volume=95; citation_publication_date=2021; citation_pages=e02415-e2420; citation_doi=10.1128/JVI.02415-20; citation_id=CR26 citation_journal_title=Cell Rep; citation_title=MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells; citation_author=X Yin, L Riva, Y Pu, L Martin-Sancho, J Kanamune, Y Yamamoto; citation_volume=34; citation_publication_date=2021; citation_pages=108628; citation_doi=10.1016/j.celrep.2020.108628; citation_id=CR27 citation_journal_title=Front Med; citation_title=Pathogenesis of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a concise review with an emphasis on type I interferon system; citation_author=H Hu, H Yang, Y Liu, B Yan; citation_volume=8; citation_publication_date=2021; citation_pages=833114; citation_doi=10.3389/fmed.2021.833114; citation_id=CR28 citation_journal_title=Eur Respir J; citation_title=Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?; citation_author=M Giannini, M Ohana, B Nespola, G Zanframundo, B Geny, A Meyer; citation_volume=56; citation_publication_date=2020; citation_pages=2001618; citation_doi=10.1183/13993003.01618-2020; citation_id=CR29 Wang Y, Du G, Zhang G, Matucci-Cerinic M, Furst DE. Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future. Ann Rheum Dis. 2022;81:e192.  https://doi.org/10.1136/annrheumdis-2020-218594 . This short review summarized cinical and pathological similarities and differences between severe COVID-19 pneumonia and anti-MDA5 antibody-positive DM-associated rapidly-progressive ILD. citation_journal_title=Clin Exp Rheumatol; citation_title=COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still’s disease; citation_author=Y Kondo, Y Kaneko, H Takei, H Tamai, H Kabata, T Suhara; citation_volume=39; citation_publication_date=2021; citation_pages=631-8; citation_doi=10.55563/clinexprheumatol/44kaji; citation_id=CR31 citation_journal_title=Immunity; citation_title=Cytokine storms: understanding COVID-19; citation_author=N Mangalmurti, CA Hunter; citation_volume=53; citation_publication_date=2020; citation_pages=19-25; citation_doi=10.1016/j.immuni.2020.06.017; citation_id=CR32 citation_journal_title=Rheumatology; citation_title=Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease; citation_author=T Gono, H Kaneko, Y Kawaguchi, M Hanaoka, S Kataoka, M Kuwana; citation_volume=53; citation_publication_date=2014; citation_pages=2196-2203; citation_doi=10.1093/rheumatology/keu258; citation_id=CR33 citation_journal_title=N Engl J Med; citation_title=Activated STING in a vascular and pulmonary syndrome; citation_author=Y Liu, AA Jesus, B Marrero, D Yang, SE Ramsey, GAM Sanchez; citation_volume=371; citation_publication_date=2014; citation_pages=507-518; citation_doi=10.1056/NEJMoa1312625; citation_id=CR34 Ali SS, R N, Sen P, Day J, Joshi M, Nune A, et al. Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology (Oxford). 2023;62:e263–e268.  https://doi.org/10.1093/rheumatology/kead149 . citation_journal_title=Clin Rheumatol; citation_title=Clinical evolution of antisynthetase syndrome after SARS-CoV2 infection: a 6-month follow-up analysis; citation_author=V Vertui, G Zanframundo, S Castañeda, A Biglia, BL Palermo, I Cavazzana; citation_volume=41; citation_publication_date=2022; citation_pages=2601-2604; citation_doi=10.1007/s10067-022-06216-w; citation_id=CR36 citation_journal_title=Immunol Res; citation_title=COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report; citation_author=V Syrmou, C Liaskos, N Ntavari, K Mitsimponas, T Simopoulou, I Alexiou; citation_volume=16; citation_publication_date=2023; citation_pages=1-10; citation_doi=10.1007/s12026-023-09368-2; citation_id=CR37 citation_journal_title=Arthritis Rheumatol; citation_title=Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following two-dose SARS-CoV-2 messenger RNA vaccination; citation_author=CM Connolly, JA Ruddy, BJ Boyarsky, I Barbur, WA Werbel, D Geetha; citation_volume=74; citation_publication_date=2022; citation_pages=28-32; citation_doi=10.1002/art.41924; citation_id=CR38 ・Naveen R, Sen P, Griger Z, Day J, Joshi M, Nune A, et al. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and 2 surveys. Rheumatology (Oxford). 2023:kead180. https://doi.org/10.1093/rheumatology/kead180 . This study evaluated the frequency of disease flare following COVID-19 vaccination in IIM patients using data obtained from an international, multicenter, e-survey. citation_journal_title=Intern Emerg Med; citation_title=Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study; citation_author=E Conticini, M d’Alessandro, S Grazzini, M Fornaro, D Sabella, G Lopalco; citation_volume=17; citation_publication_date=2022; citation_pages=1921-1928; citation_doi=10.1007/s11739-022-03028-3; citation_id=CR40 citation_journal_title=Muscle Nerve; citation_title=Incidence, features, and outcome of disease relapse after COVID-19 vaccination in patients with idiopathic inflammatory myopathies; citation_author=M Nagy-Vincze, T Béldi, K Szab, A Vincze, B Miltényi-Szab, M Student; citation_volume=67; citation_publication_date=2023; citation_pages=371-377; citation_doi=10.1002/mus.27811; citation_id=CR41 citation_journal_title=J Am Acad Dermatol; citation_title=Disease flare in patients with dermatomyositis following COVID-19 vaccination; citation_author=BACX Pan, NG Ba, BSDY Kim, RRBS Ms, MS Bs, MDMPHA LaChance; citation_volume=87; citation_publication_date=2022; citation_pages=1373-1374; citation_doi=10.1016/j.jaad.2022.07.010; citation_id=CR42 citation_journal_title=Cell Biol Int; citation_title=COVID-19: a trigger of autoimmune diseases; citation_author=A Zebardast, A Hasanzadeh, SA Ebrahimian Shiadeh, M Tourani, Y Yahyapour; citation_volume=47; citation_publication_date=2023; citation_pages=848-858; citation_doi=10.1002/cbin.11997; citation_id=CR43 citation_journal_title=Commun Biol; citation_title=Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis; citation_author=S Megremis, TDJ Walker, X He, J O’Sullivan, WER Ollier, H Chinoy; citation_volume=4; citation_publication_date=2021; citation_pages=419; citation_doi=10.1038/s42003-021-01932-6; citation_id=CR44 Megremis S, Walker TDJ, He X, Ollier WER, Chinoy H, Hampson L, et al. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis. Ann Rheum Dis. 2020;79:1383–6.  https://doi.org/10.1136/annrheumdis-2020-217522 . This study indicated that coronaviruses infection may trigger autoimmunity against TIF1-γ through molecular mimicry. Rodero MP, Pelleau S, Welfringer-Morin A, FJDM study group, Duffy D, Melki I, et al. Onset and relapse of juvenile dermatomyositis following asymptomatic SARS-CoV-2 infection. J Clin Immunol. 2022;42:25–7.  https://doi.org/10.1007/s10875-021-01119-y . citation_journal_title=Ann Rheum Dis; citation_title=Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study; citation_author=J Svensson, M Holmqvist, IE Lundberg, EV Arkema; citation_volume=76; citation_publication_date=2017; citation_pages=1803-1808; citation_doi=10.1136/annrheumdis-2017-211174; citation_id=CR47 citation_journal_title=RMD Open; citation_title=Inflammatory lung disease a potential risk factor for onset of idiopathic inflammatory myopathies: results from a pilot study; citation_author=SB Helmers, X Jiang, D Pettersson, A-L Wikman, P Axelman, Å Lundberg; citation_volume=2; citation_publication_date=2016; citation_pages=e000342; citation_doi=10.1136/rmdopen-2016-000342; citation_id=CR48 citation_journal_title=Autoimmunity; citation_title=Polymyositis-dermatomyositis and infections; citation_author=S Zampieri, A Ghirardello, L Iaccarino, C Briani, P Sarzi-Puttini, F Atzeni; citation_volume=39; citation_publication_date=2006; citation_pages=191-196; citation_doi=10.1080/08916930600622348; citation_id=CR49 citation_journal_title=Rheumatol (Oxford); citation_title=Childhood Myositis Heterogeneity Collaborative Study Group. Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies; citation_author=LG Rider, L Wu, G Mamyrova, IN Targoff, FW Miller; citation_volume=49; citation_publication_date=2010; citation_pages=2381-90; citation_doi=10.1093/rheumatology/keq277; citation_id=CR50 citation_journal_title=J Autoimmun; citation_title=Infections as risk factor for autoimmune diseases—a nationwide study; citation_author=PR Nielsen, TW Kragstrup, BW Deleuran, ME Benros; citation_volume=74; citation_publication_date=2016; citation_pages=176-181; citation_doi=10.1016/j.jaut.2016.05.013; citation_id=CR51 citation_journal_title=Ann N Y Acad Sci; citation_title=Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report; citation_author=O Barzilai, Y Sherer, M Ram, D Izhaky, JM Anaya, Y Shoenfeld; citation_volume=1108; citation_publication_date=2007; citation_pages=567-577; citation_doi=10.1196/annals.1422.059; citation_id=CR52 citation_journal_title=Neurology; citation_title=Hepatitis C virus infection in inclusion body myositis: a case-control study; citation_author=A Uruha, S Noguchi, YK Hayashi, RS Tsuburaya, T Yonekawa, I Nonaka; citation_volume=86; citation_publication_date=2016; citation_pages=211-217; citation_doi=10.1212/WNL.0000000000002291; citation_id=CR53 citation_journal_title=J Immunol; citation_title=T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells; citation_author=AER Fasth, M Dastmalchi, A Rahbar, S Salomonsson, JM Pandya, E Lindroos; citation_volume=183; citation_publication_date=2009; citation_pages=4792-4799; citation_doi=10.4049/jimmunol.0803688; citation_id=CR54 citation_journal_title=Parasitol Res; citation_title=Parasitic infections and myositis; citation_author=SN El-Beshbishi, NN Ahmed, SH Mostafa, GA El-Ganainy; citation_volume=110; citation_publication_date=2012; citation_pages=1-18; citation_doi=10.1007/s00436-011-2609-8; citation_id=CR55 citation_journal_title=J Rheumatol; citation_title=Penicillamine induced polymyositis and dermatomyositis; citation_author=GJ Carroll, RK Will, JB Peter, MJ Garlepp, RL Dawkins; citation_volume=14; citation_publication_date=1987; citation_pages=995-1001; citation_id=CR56 citation_journal_title=Arthritis Rheum; citation_title=D-penicillamine-induced polymyositis in patients with rheumatoid arthritis; citation_author=K Takahashi, T Ogita, H Okudaira, S Yoshinoya, H Yoshizawa, T Miyamoto; citation_volume=29; citation_publication_date=1986; citation_pages=560-564; citation_doi=10.1002/art.1780290416; citation_id=CR57 citation_journal_title=Cancer; citation_title=Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinoma; citation_author=FJ Esteva-Lorenzo, JE Janik, RG Fenton, A Emslie-Smith, AG Engel, DL Longo; citation_volume=76; citation_publication_date=1995; citation_pages=1219-1223; citation_doi=10.1002/1097-0142(19951001)76:7<1219::aid-cncr2820760719>3.0.co;2-o; citation_id=CR58 citation_journal_title=ScientificWorldJournal; citation_title=New onset of dermatomyositis/polymyositis during anti-TNF-α therapies: a systematic literature review; citation_author=AMG Brunasso, W Aberer, C Massone; citation_volume=2014; citation_publication_date=2014; citation_pages=179180; citation_doi=10.1155/2014/179180; citation_id=CR59 citation_journal_title=Rheumatol Int; citation_title=Polymyositis occurring during α-interferon treatment for malignant melanoma: a case report and review of the literature; citation_author=G Cirigliano, A Della Rossa, A Tavoni, P Viacava, S Bombardieri; citation_volume=19; citation_publication_date=1999; citation_pages=65-67; citation_doi=10.1007/s002960050103; citation_id=CR60 citation_journal_title=Neurology; citation_title=Myositis during long-term interferon-alpha treatment; citation_author=GJ Hengstman, OJ Vogels, HJ Laak, T Witte, BG Engelen; citation_volume=54; citation_publication_date=2000; citation_pages=2186; citation_doi=10.1212/wnl.54.11.2186; citation_id=CR61 citation_journal_title=N Engl J Med; citation_title=Statin-associated autoimmune myopathy; citation_author=AL Mammen; citation_volume=374; citation_publication_date=2016; citation_pages=664-669; citation_doi=10.1056/NEJMra1515161; citation_id=CR62 citation_journal_title=Arthritis Rheum; citation_title=A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy; citation_author=L Christopher-Stine, LA Casciola-Rosen, G Hong, T Chung, AM Corse, AL Mammen; citation_volume=62; citation_publication_date=2010; citation_pages=2757-2766; citation_doi=10.1002/art.27572; citation_id=CR63 citation_journal_title=Clin Exp Rheumatol; citation_title=Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy Comparative analysis of a single-centre cohort and published data; citation_author=J-G Rademacher, S Glaubitz, S Zechel, M Oettler, B Tampe, J Schmidt; citation_volume=40; citation_publication_date=2022; citation_pages=320-8; citation_doi=10.55563/clinexprheumatol/2ao5ze; citation_id=CR64 citation_journal_title=Rheumatology; citation_title=More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy; citation_author=E Tiniakou, I Pinal-Fernandez, TE Lloyd, J Albayda, J Paik, JL Werner; citation_volume=56; citation_publication_date=2017; citation_pages=787-794; citation_doi=10.1093/rheumatology/kew470; citation_id=CR65 citation_journal_title=Arthritis Rheum; citation_title=Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy; citation_author=AL Mammen, T Chung, L Christopher-Stine, P Rosen, A Rosen, KR Doering; citation_volume=63; citation_publication_date=2011; citation_pages=713-721; citation_doi=10.1002/art.30156; citation_id=CR66 citation_journal_title=Muscle Nerve; citation_title=Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies: anti-HMGCR-Associated Myopathy; citation_author=P Mohassel, AL Mammen; citation_volume=48; citation_publication_date=2013; citation_pages=477-483; citation_doi=10.1002/mus.23854; citation_id=CR67 citation_journal_title=Arthritis Rheum; citation_title=Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy; citation_author=JL Werner, L Christopher-Stine, SR Ghazarian, KS Pak, JE Kus, NR Daya; citation_volume=64; citation_publication_date=2012; citation_pages=4087-4093; citation_doi=10.1002/art.34673; citation_id=CR68 citation_journal_title=JAMA Intern Med; citation_title=Association of statin exposure with histologically confirmed idiopathic inflammatory myositis in an Australian population; citation_author=GE Caughey, GM Gabb, S Ronson, M Ward, T Beukelman, CL Hill; citation_volume=178; citation_publication_date=2018; citation_pages=1224-1229; citation_doi=10.1001/jamainternmed.2018.2859; citation_id=CR69 Wei J, Ketner E, Mammen AL (2022) Increased risk of statin-associated autoimmune myopathy among American Indians. Arthritis Rheumatol 74:1602–3. https://doi.org/10.1002/art.42126 . This study suggested an increased risk of statin-associated autoimmune myopathy in native Americans. citation_journal_title=Rheumatology; citation_title=Potential implications of six American Indian patients with myopathy, statin exposure and anti-HMGCR antibodies; citation_author=RM Close, LM Close, P Galdun, S Gerstberger, M Rydberg, L Christopher-Stine; citation_volume=60; citation_publication_date=2021; citation_pages=692-698; citation_doi=10.1093/rheumatology/keaa337; citation_id=CR71 citation_journal_title=Arthritis Care Res; citation_title=Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy; citation_author=AL Mammen, D Gaudet, D Brisson, L Christopher-Stine, TE Lloyd, MS Leffell; citation_volume=64; citation_publication_date=2012; citation_pages=1233-1237; citation_doi=10.1002/acr.21671; citation_id=CR72 citation_journal_title=Cardiovasc Res; citation_title=Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence; citation_author=LR Brunham, S Baker, A Mammen, GBJ Mancini, RS Rosenson; citation_volume=114; citation_publication_date=2018; citation_pages=1073-1081; citation_doi=10.1093/cvr/cvy119; citation_id=CR73 citation_journal_title=N Engl J Med; citation_title=Immune-related adverse events associated with immune checkpoint blockade; citation_author=MA Postow, R Sidlow, MD Hellmann; citation_volume=378; citation_publication_date=2018; citation_pages=158-168; citation_doi=10.1056/NEJMra1703481; citation_id=CR74 citation_journal_title=Clin Exp Rheumatol; citation_title=Immune checkpoint inhibitor-related myositis: from pathophysiology to treatment; citation_author=C Sundarrajan, S Bhai, MM Dimachkie; citation_volume=41; citation_publication_date=2023; citation_pages=379-85; citation_doi=10.55563/clinexprheumatol/q7mdjs; citation_id=CR75 citation_journal_title=Autoimmun Rev; citation_title=Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities; citation_author=Y Allenbach, C Anquetil, A Manouchehri, O Benveniste, O Lambotte, B Lebrun-Vignes; citation_volume=19; citation_publication_date=2020; citation_pages=102586; citation_doi=10.1016/j.autrev.2020.102586; citation_id=CR76 citation_journal_title=Ann Rheum Dis; citation_title=Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO’s adverse drug reactions database; citation_author=T Nguyễn, ATJ Maria, C Ladhari, P Palassin, X Quantin, C Lesage; citation_volume=81; citation_publication_date=2022; citation_pages=e32; citation_doi=10.1136/annrheumdis-2020-217018; citation_id=CR77 citation_journal_title=J Autoimmun; citation_title=Inflammatory myopathy associated with PD-1 inhibitors; citation_author=M Seki, A Uruha, Y Ohnuki, S Kamada, T Noda, A Onda; citation_volume=100; citation_publication_date=2019; citation_pages=105-113; citation_doi=10.1016/j.jaut.2019.03.005; citation_id=CR78 citation_journal_title=Front Immunol; citation_title=Incidence and distinct features of immune checkpoint inhibitor-related myositis from idiopathic inflammatory myositis: a single-center experience with systematic literature review and meta-analysis; citation_author=N Hamada, A Maeda, K Takase-Minegishi, Y Kirino, Y Sugiyama, H Namkoong; citation_volume=12; citation_publication_date=2021; citation_pages=803410; citation_doi=10.3389/fimmu.2021.803410; citation_id=CR79 citation_journal_title=JAMA Neurol; citation_title=Neurological complications associated with anti–programmed death 1 (PD-1) antibodies; citation_author=JC Kao, B Liao, SN Markovic, CJ Klein, E Naddaf, Nathan P Staff; citation_volume=74; citation_publication_date=2017; citation_pages=1216-22; citation_doi=10.1001/jamaneurol.2017.1912; citation_id=CR80 citation_journal_title=Circulation; citation_title=Immune checkpoint inhibitor-associated myositis: expanding the spectrum of cardiac complications of the immunotherapy revolution; citation_author=C Anquetil, J-E Salem, B Lebrun-Vignes, DB Johnson, AL Mammen, W Stenzel; citation_volume=138; citation_publication_date=2018; citation_pages=743-745; citation_doi=10.1161/CIRCULATIONAHA.118.035898; citation_id=CR81 citation_journal_title=Neurology; citation_title=Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer; citation_author=M Touat, T Maisonobe, S Knauss, O Ben Hadj Salem, B Hervier, K Auré; citation_volume=91; citation_publication_date=2018; citation_pages=e985-94; citation_doi=10.1212/WNL.0000000000006124; citation_id=CR82 Aldrich J, Pundole X, Tummala S, Palaskas N, Andersen CR, Shoukier M, et al. Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors. Arthritis Rheumatol. 2021;73:866–74. https://doi.org/10.1002/art.41604 . This large-scale retrospective cohort study described the incidence, clinical characteristics, patterns of care, and outcomes of patints with ICI-related myositis. citation_journal_title=Sci Rep; citation_title=Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis; citation_author=K Kufukihara, Y Watanabe, T Inagaki, K Takamatsu, S Nakane, J Nakahara; citation_volume=9; citation_publication_date=2019; citation_pages=5284; citation_doi=10.1038/s41598-019-41730-z; citation_id=CR84 Suzuki S Significance of antistriational antibodies for immune checkpoint inhibitor-related myositis: comment on the article by Aldrich et al. Arthritis Rheumatol 2021;73:1563–4 https://doi.org/10.1002/art.41713 citation_journal_title=Curr Rheumatol Rep; citation_title=Immune checkpoint inhibitor-induced myositis: a case report and literature review; citation_author=H Kadota, T Gono, Y Shirai, Y Okazaki, M Takeno, M Kuwana; citation_volume=21; citation_publication_date=2019; citation_pages=10; citation_doi=10.1007/s11926-019-0811-3; citation_id=CR86 ・・Pinal-Fernandez I, Quintana A, Milisenda JC, Casal-Dominguez M, Muñoz-Braceras S, Derfoul A, et al. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis. Ann Rheum Dis. 2023;82:829–36. https://doi.org/10.1136/ard-2022-223792 This study identified three distinct subsets of ICI-related myositis using transcriptomic analysis on muscle biopsy samples. citation_journal_title=Rheumatology; citation_title=Environmental factors associated with disease flare in juvenile and adult dermatomyositis; citation_author=G Mamyrova, LG Rider, A Ehrlich, O Jones, LM Pachman, R Nickeson; citation_volume=56; citation_publication_date=2017; citation_pages=1342-1347; citation_doi=10.1093/rheumatology/kex162; citation_id=CR88 citation_journal_title=Arthritis Care Res; citation_title=Association of ultraviolet radiation exposure with dermatomyositis in a national myositis patient registry; citation_author=CG Parks, J Wilkerson, KM Rose, A Faiq, P Noroozi Farhadi, CS Long; citation_volume=72; citation_publication_date=2020; citation_pages=1636-1644; citation_doi=10.1002/acr.24059; citation_id=CR89 citation_journal_title=Arthritis Rheum; citation_title=International Myositis Collaborative Study Group. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease; citation_author=S Okada, E Weatherhead, IN Targoff, R Wesley, FW Miller; citation_volume=48; citation_publication_date=2003; citation_pages=2285-93; citation_doi=10.1002/art.11090; citation_id=CR90 citation_journal_title=Arthritis Rheum; citation_title=Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women; citation_author=LA Love, CR Weinberg, DR McConnaughey, CV Oddis, TA Medsger, JD Reveille; citation_volume=60; citation_publication_date=2009; citation_pages=2499-2504; citation_doi=10.1002/art.24702; citation_id=CR91 citation_journal_title=Arthritis Rheum; citation_title=with the Childhood Myositis Heterogeneity Collaborative Study Group. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis: ultraviolet radiation exposure and juvenile myositis phenotypes; citation_author=M Shah, IN Targoff, MM Rice, FW Miller, LG Rider; citation_volume=65; citation_publication_date=2013; citation_pages=1934-41; citation_doi=10.1002/art.37985; citation_id=CR92 citation_journal_title=Arthritis Care Res (Hoboken); citation_title=Association of short-term ultraviolet radiation exposure and disease severity in juvenile dermatomyositis: results from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry; citation_author=J Neely, CS Long, H Sturrock, S Kim; citation_volume=71; citation_publication_date=2019; citation_pages=1600-5; citation_doi=10.1002/acr.23840; citation_id=CR93 Aguilar-Vazquez A, Chavarria-Avila E, Pizano-Martinez O, Ramos-Hernandez A, Andrade-Ortega L, Rubio-Arellano E-D, et al. Geographical latitude remains as an important factor for the prevalence of some myositis autoantibodies: a systematic review. Front Immunol. 2021;12:672008. https://doi.org/10.3389/fimmu.2021.672008 . This systematic literature review featured the relationship between geographical latitude and the prevalence of MSAs/MAAs. citation_journal_title=Front Immunol; citation_title=Human and Murine evidence for mechanisms driving autoimmune photosensitivity; citation_author=SJ Wolf, SN Estadt, JE Gudjonsson, JM Kahlenberg; citation_volume=9; citation_publication_date=2018; citation_pages=2430; citation_doi=10.3389/fimmu.2018.02430; citation_id=CR95 citation_journal_title=J Biol Chem; citation_title=UV radiation regulates Mi-2 through protein translation and stability; citation_author=CJ Burd, HK Kinyamu, FW Miller, TK Archer; citation_volume=283; citation_publication_date=2008; citation_pages=34976-34982; citation_doi=10.1074/jbc.M805383200; citation_id=CR96 citation_journal_title=Ann Rheum Dis; citation_title=Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study; citation_author=H Chinoy, S Adimulam, F Marriage, P New, M Vincze, E Zilahi; citation_volume=71; citation_publication_date=2012; citation_pages=961-5; citation_doi=10.1136/annrheumdis-2011-200182; citation_id=CR97 citation_journal_title=Semin Arthritis Rheum.; citation_title=The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis; citation_author=A Schiffenbauer, S Faghihi-Kashani, TP O’Hanlon, WA Flegel, SD Adams, IN Targoff; citation_volume=48; citation_publication_date=2018; citation_pages=504-12; citation_doi=10.1016/j.semarthrit.2018.02.003; citation_id=CR98 citation_journal_title=Ann Rheum Dis; citation_title=The EuroMyositis registry: an international collaborative tool to facilitate myositis research; citation_author=JB Lilleker, J Vencovsky, G Wang, LR Wedderburn, LP Diederichsen, J Schmidt; citation_volume=77; citation_publication_date=2018; citation_pages=30-39; citation_doi=10.1136/annrheumdis-2017-211868; citation_id=CR99 citation_journal_title=Arthritis Rheum; citation_title=Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis: the target tissue in Jo-1 autoantibody-associated myositis; citation_author=SM Levine, N Raben, D Xie, FB Askin, R Tuder, M Mullins; citation_volume=56; citation_publication_date=2007; citation_pages=2729-2739; citation_doi=10.1002/art.22790; citation_id=CR100 Galindo-Feria AS, Albrecht I, Fernandes-Cerqueira C, Notarnicola A, James EA, Herrath J, et al. Proinflammatory histidyl-transfer RNA synthetase-specific CD4+ T cells in the blood and lungs of patients with idiopathic inflammatory myopathies. Arthritis Rheumatol. 2020;72:179–91. https://doi.org/10.1002/art.41075 . This study proposed a potential mechanism by which inhalation stimuli trigger the production of anti-Jo-1 antibodies. citation_journal_title=ACR Open Rheumatol; citation_title=Inorganic dust exposure during military service as a predictor of rheumatoid arthritis and other autoimmune conditions; citation_author=D Ying, G Schmajuk, L Trupin, PD Blanc; citation_volume=3; citation_publication_date=2021; citation_pages=466-474; citation_doi=10.1002/acr2.11273; citation_id=CR102 citation_journal_title=Am J Med; citation_title=Prospective risk of rheumatologic disease associated with occupational exposure in a cohort of male construction workers; citation_author=PD Blanc, B Järvholm, K Torén; citation_volume=128; citation_publication_date=2015; citation_pages=1094-1101; citation_doi=10.1016/j.amjmed.2015.05.001; citation_id=CR103 citation_journal_title=Arthritis Rheumatol; citation_title=Systemic autoimmune disease among adults exposed to the September 11, 2001 terrorist attack; citation_author=SA Miller-Archie, PM Izmirly, JR Berman, J Brite, DJ Walker, RC Dasilva; citation_volume=72; citation_publication_date=2020; citation_pages=849-859; citation_doi=10.1002/art.41175; citation_id=CR104 citation_journal_title=Int J Environ Res Public Health; citation_title=The relationship between 9/11 exposure, systemic autoimmune disease, and post-traumatic stress disorder: a mediational analysis; citation_author=J Brite, SA Miller-Archie, J Cone; citation_volume=19; citation_publication_date=2022; citation_pages=6514; citation_doi=10.3390/ijerph19116514; citation_id=CR105 citation_journal_title=Clin Rheumatol; citation_title=Occupational exposure in patients with the antisynthetase syndrome; citation_author=A Labirua-Iturburu, A Selva-O’Callaghan, J-P Zock, R Orriols, X Martínez-Gómez, M Vilardell-Tarrés; citation_volume=33; citation_publication_date=2014; citation_pages=221-5; citation_doi=10.1007/s10067-013-2467-0; citation_id=CR106 citation_journal_title=Arthritis Res Ther; citation_title=Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome; citation_author=A Notarnicola, C Preger, SL Lundström, N Renard, E Wigren, E Gompel; citation_volume=24; citation_publication_date=2022; citation_pages=62; citation_doi=10.1186/s13075-022-02745-6; citation_id=CR107 citation_journal_title=Curr Rheumatol Rep; citation_title=Antisynthetase syndrome; citation_author=E Katzap, M-L Barilla-LaBarca, G Marder; citation_volume=13; citation_publication_date=2011; citation_pages=175-181; citation_doi=10.1007/s11926-011-0176-8; citation_id=CR108 citation_journal_title=Nat Rev Rheumatol; citation_title=Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19; citation_author=M Cutolo, V Smith, S Paolino, E Gotelli; citation_volume=19; citation_publication_date=2023; citation_pages=265-287; citation_doi=10.1038/s41584-023-00944-2; citation_id=CR109 citation_journal_title=Ann Rheum Dis; citation_title=Low serum levels of vitamin D in idiopathic inflammatory myopathies; citation_author=P Azali, S Barbasso Helmers, I Kockum, T Olsson, L Alfredsson, PJ Charles; citation_volume=72; citation_publication_date=2013; citation_pages=512-516; citation_doi=10.1136/annrheumdis-2012-201849; citation_id=CR110 citation_journal_title=Front Immunol; citation_title=Decreased serum 25-(OH)-D level associated with muscle enzyme and myositis specific autoantibodies in patients with idiopathic inflammatory myopathy; citation_author=Z Yu, H Cheng, Y Liang, T Ding, C Yan, C Gao; citation_volume=12; citation_publication_date=2021; citation_pages=642070; citation_doi=10.3389/fimmu.2021.642070; citation_id=CR111 citation_journal_title=Arthritis Rheum; citation_title=Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies; citation_author=RL Leff, SH Burgess, FW Miller, LA Love, IN Targoff, MC Dalakas; citation_volume=34; citation_publication_date=1991; citation_pages=1391-1396; citation_doi=10.1002/art.1780341108; citation_id=CR112 citation_journal_title=Arthritis Rheum; citation_title=Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups; citation_author=K Sarkar, CR Weinberg, CV Oddis, TA Medsger, PH Plotz, JD Reveille; citation_volume=52; citation_publication_date=2005; citation_pages=2433-2438; citation_doi=10.1002/art.21198; citation_id=CR113 Nishina N, Sato S, Masui K, Gono T, Kuwana M. Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease. RMD Open. 2020;6;e001202. https://doi.org/10.1136/rmdopen-2020-001202 . This study demonstrated the association of seasonality and residence with the onset of anti-MDA5-associated ILD using a multicenter retrospective cohort. citation_journal_title=Front Med; citation_title=Seasonal effect on disease onset and presentation in anti-MDA5 positive dermatomyositis; citation_author=H So, J So, TT-O Lam, VT-L Wong, R Ho, WL Li; citation_volume=9; citation_publication_date=2022; citation_pages=837024; citation_doi=10.3389/fmed.2022.837024; citation_id=CR115 citation_journal_title=Autoimmun Rev; citation_title=The seasonality of Dermatomyositis associated with anti-MDA5 antibody: an argument for a respiratory viral trigger; citation_author=S Toquet, B Granger, Y Uzunhan, K Mariampillai, H Nunes, O Benveniste; citation_volume=20; citation_publication_date=2021; citation_pages=102788; citation_doi=10.1016/j.autrev.2021.102788; citation_id=CR116 citation_journal_title=Expert Rev Anti Infect Ther; citation_title=Influenza and other respiratory viruses: standardizing disease severity in surveillance and clinical trials; citation_author=B Rath, T Conrad, P Myles, M Alchikh, X Ma, C Hoppe; citation_volume=15; citation_publication_date=2017; citation_pages=545-568; citation_doi=10.1080/14787210.2017.1295847; citation_id=CR117 citation_journal_title=Semin Arthritis Rheum; citation_title=Prevalence of interstitial lung disease in polymyositis and dermatomyositis: a meta-analysis from 2000 to 2020; citation_author=K-Y Sun, Y Fan, Y-X Wang, Y-J Zhong, G-F Wang; citation_volume=51; citation_publication_date=2021; citation_pages=175-191; citation_doi=10.1016/j.semarthrit.2020.11.009; citation_id=CR118 citation_journal_title=Curr Opin Rheumatol; citation_title=Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis: insights into disease pathogenesis; citation_author=S Rothwell, H Chinoy, JA Lamb; citation_volume=31; citation_publication_date=2019; citation_pages=611-616; citation_doi=10.1097/BOR.0000000000000652; citation_id=CR119 citation_journal_title=Arthritis Res Ther; citation_title=Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan; citation_author=Y Muro, K Sugiura, K Hoshino, M Akiyama, K Tamakoshi; citation_volume=13; citation_publication_date=2011; citation_pages=R214; citation_doi=10.1186/ar3547; citation_id=CR120